A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
一项针对转移性去势抵抗性前列腺癌的Acapatamab(一种半衰期延长、靶向PSMA的双特异性T细胞衔接剂)的I期研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-2978
Dorff, Tanya; Horvath, Lisa G; Autio, Karen; Bernard-Tessier, Alice; Rettig, Matthew B; Machiels, Jean-Pascal; Bilen, Mehmet A; Lolkema, Martijn P; Adra, Nabil; Rottey, Sylvie; Greil, Richard; Matsubara, Nobuaki; Tan, Daniel S W; Wong, Alvin; Uemura, Hiroji; Lemech, Charlotte; Meran, Johannes; Yu, Youfei; Minocha, Mukul; McComb, Mason; Penny, Hweixian Leong; Gupta, Vinita; Hu, Xuguang; Jurida, Gabor; Kouros-Mehr, Hosein; Janát-Amsbury, Margit M; Eggert, Tobias; Tran, Ben
肿瘤
T细胞
肿瘤免疫
T细胞
细胞生物学
前列腺癌
免疫/内分泌